K.C. Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
K.C. Pharmaceuticals is recalling 505,896 cartons of artificial tears sold under multiple brands because the product lacks assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II due to a lack of assurance of sterility in an ophthalmic product. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
K.C. Pharmaceuticals, Inc. is recalling 505,896 cartons of artificial tears (polyvinyl alcohol 0.5%, povidone 0.6%) in 15 mL bottles. The recall is due to a lack of assurance of sterility. The affected product is distributed nationwide under various brand names, including Leader, Good Neighbor Pharmacy, Good Sense, Medic'c Choice, Quality Choice, TopCare Health, Walgreens, and Kroger.
The recall covers specific lot numbers with expiration dates ranging from November 30, 2026, to September 30, 2027. Consumers should check their bottles for the lot numbers and expiration dates listed in the recall notice. If the product matches the recalled lots, consumers should stop using it and return it to the place of purchase for a refund or contact the manufacturer for further instructions.
The recalled product
- Product
- LEADER ARTIFICIAL TEARS 15 ML (POLYVINYL ALCOHOL, POVIDONE)
- Brand
- LEADER ARTIFICIAL TEARS 15 ML
- Manufacturer
- K.C. Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 505,896
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: a) AT25B01
- Exp.: 2/28/2027
- b) AT24N01
- Exp.: 11/30/2026
- AT25B01
- AT25D01
- Exp.: 04/30/27
- AT25F01
- Exp.: 6/30/2027
- AT25F02
- AT25K02
- Exp.: 9/30/2027
- c) AT25D01
- d) AT24N01
- AT25K01
- e) AT25B01
- f) AT25B01
- g) AT25B01
- h) AT25B01
- I) AT25D01
UPCs (10)
- 0096295137644
- 0087701104060
- 0180410000163
- 0095072015519
- 0635515992238
- 070038470083
- 041415009769
- 036800093317
- 311917065038
- 011110386007
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LEADER ARTIFICIAL TEARS 15 ML
- HighLeader artificial tears 15 mL recalled over sterility assurance failure
FDA (Drugs) · 2026-04-08
Same manufacturer · K.C. Pharmaceuticals, Inc.
See all →- SevereGood Sense Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Ultra Lubricating Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Same hazard · sterility
See all →- SevereCarolina Infusion Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereApothecary Pharma Recalls Tirzepatide Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereApothecary NAD+ Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14
Similar recalls
- HighLeader artificial tears 15 mL recalled over sterility assurance failure
FDA (Drugs) · 2026-04-08
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Ultra Lubricating Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighArtificial tears glycerin drops recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-08
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14